drugset / Trial / NCT05649059
Investigating the Effects of Cannabidiol on Social Anxiety Disorder
Phase 4
Recruiting
50 enrolled
Massachusetts Institute of Technology
Massachusetts General Hospital · collab
RandomizedParallel-groupQuadruple-blindOther
Summary
The purpose of this study is to test whether a single-dose of Epidiolex (cannabidiol) is associated with reduced psychological, physiological, and neuroimaging measures of anxiety in people diagnosed with social anxiety disorder (SAD).
Timeline
- Start
- 2025-07-10
- Primary completion
- 2026-05
- Completion
- 2026-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Cannabidiol | Other / unclassified | 300 mg | Oral |